Multipharma
Timeline
171 events since 2004The 2026 accounts are due by 31-07-2027.
resigns as member of the executive committeeBoard meeting of 11-06-202610 points ▸
- Board meeting of 11-06-2026
- resigns as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- General meeting of 26-09-2025
- Operation treated as a merger by absorption
- The company holds all the shares of Farmannso
- The operation takes effect in the accounts on 01-01-2025
- Power of attorney granted to (lasthebber)
- The deed holds 7 more points.
Merger proposal: MULTIPHARMA takes over Farmannso4 points ▸
- Merger, 05-08-2025
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 6 more points.
1 director appointed, 1 resignation, 3 reappointments, 1 statutory auditor reappointed resigns · appointed · , , and (statutory auditor) reappointed · General meeting of 12-06-20258 points ▸
- General meeting of 12-06-2025
- resigns as director
- appointed as director
- reappointed as director
- reappointed as director
- reappointed as director
- reappointed as statutory auditor
- acts as permanent representative
Merger: MULTIPHARMA takes over APOPLUS, ApoLierConsult, PHARMACIE DEBELLE, IMMOBOX and STENAPHARThe company holds all the shares of APOPLUS · The company holds all the shares of ApoLierConsult · The company holds all the shares of PHARMACIE DEBELLE · General meeting of 12-06-20259 points ▸
- General meeting of 12-06-2025
- The company holds all the shares of APOPLUS
- The company holds all the shares of ApoLierConsult
- The company holds all the shares of PHARMACIE DEBELLE
- The company holds all the shares of IMMOBOX
- The company holds all the shares of STENAPHAR
- The operation takes effect in the accounts on 01-01-2025
- Power of attorney granted to (lasthebber)
- Power of attorney granted to (managing director)
- The deed holds 6 more points.
Merger proposal: MULTIPHARMA takes over APOPLUS, APOLIERCONSULT, PHARMACIE DEBELLE, IMMOBOX and STENAPHARBoard meeting of 03-04-20253 points ▸
- Board meeting of 03-04-2025
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-01-2025
- The deed holds 5 more points.
Powers of attorney granted to , and 5 othersBoard meeting of 04-02-20258 points ▸
- Board meeting of 04-02-2025
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
appointed as member of the executive committeeBoard meeting of 24-10-202411 points ▸
- Board meeting of 24-10-2024
- appointed as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
- is in office as member of the executive committee
(managing director) and (director) reappointedGeneral meeting of 13-06-20245 points ▸
- General meeting of 13-06-2024
- reappointed as director
- reappointed as director
- Board meeting of 13-06-2024
- reappointed as managing director
Merger: MULTIPHARMA takes over ARJURO, BREPHAR, EURAUTO CARS SERVICES and APOTHEEK BOGAERTThe company holds all the shares of ARJURO · The company holds all the shares of BREPHAR · The company holds all the shares of EURAUTO CARS SERVICES · General meeting of 13-06-20248 points ▸
- General meeting of 13-06-2024
- Merger by absorption
- The company holds all the shares of ARJURO
- The company holds all the shares of BREPHAR
- The company holds all the shares of EURAUTO CARS SERVICES
- The company holds all the shares of APOTHEEK BOGAERT
- The operation takes effect in the accounts on 01-01-2024
- Power of attorney granted to (managing director)
- The deed holds 8 more points.
Powers of attorney granted to , and 5 others is in office as managing director · is in office as financial director · Board meeting of 19-10-20239 points ▸
- Board meeting of 19-10-2023
- Power of attorney granted to (managing director)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (financial director)
Merger proposal: MULTIPHARMA takes over ARJURO, BREPHAR, EURAUTO CARS SERVICES SPRL and APOTHEEK BOGAERT2 points ▸
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-01-2024
- The deed holds 6 more points.
Powers of attorney granted to , and 5 others is in office as managing director · is in office as financial director · Board meeting of 19-10-20238 points ▸
- Board meeting of 19-10-2023
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
(managing director) and (chair of the board) reappointedBoard meeting of 30-11-20233 points ▸
- Board meeting of 30-11-2023
- reappointed as managing director
- reappointed as chair of the board
Powers of attorney granted to , and 5 othersBoard meeting of 08-06-20238 points ▸
- Board meeting of 08-06-2023
- Power of attorney granted to (managing director)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
Merger: MULTIPHARMA takes over PHARMACIE MARIAGE-CLABOTS, FARMA 2000 and PHARMACIE LYONThe company holds all the shares of PHARMACIE MARIAGE-CLABOTS · The company holds all the shares of FARMA 2000 · The company holds all the shares of PHARMACIE LYON · General meeting of 08-06-20238 points ▸
- General meeting of 08-06-2023
- Merger by absorption
- The company holds all the shares of PHARMACIE MARIAGE-CLABOTS
- The company holds all the shares of FARMA 2000
- The company holds all the shares of PHARMACIE LYON
- The operation takes effect in the accounts on 01-01-2023
- Power of attorney granted to (mandate holder)
- Power of attorney granted to (managing director)
- The deed holds 6 more points.
Powers of attorney granted to , and 5 others is in office as managing director · Board meeting of 06-04-20238 points ▸
- Board meeting of 06-04-2023
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
Merger proposal: MULTIPHARMA takes over PHARMACIE MARIAGE-CLABOTS, FARMA 2000 and PHARMACIE LYON2 points ▸
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-01-2023
- The deed holds 3 more points.
1 statutory auditor appointed, 4 directors reappointed, , and reappointed · appointed as statutory auditor · acts as permanent representative · General meeting of 09-06-2022 · published again on 05-09-20228 points ▸
- General meeting of 09-06-2022
- reappointed as director
- reappointed as director
- reappointed as director
- reappointed as director
- appointed as statutory auditor
- acts as permanent representative
- appointed as statutory auditor
Powers of attorney granted to , and 5 othersBoard meeting of 24-03-20228 points ▸
- Board meeting of 24-03-2022
- Power of attorney granted to (director)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (proxy holder)
- Power of attorney granted to (marıdataris)
- Power of attorney granted to (proxy holder)
Merger: MULTIPHARMA takes over CL PHARMA, APOTEEK VAN SCHEL, PHARMACIE MARY, and PHARMACIE MARENGOIn the same merger MULTIPHARMA also took over APOTHEEK VAN WEMMEL. · The company holds all the shares of CL PHARMA · The company holds all the shares of APOTEEK VAN SCHEL · The company holds all the shares of PHARMACIE MARY · General meeting of 09-06-202210 points ▸
- General meeting of 09-06-2022
- Merger by absorption
- The company holds all the shares of CL PHARMA
- The company holds all the shares of APOTEEK VAN SCHEL
- The company holds all the shares of PHARMACIE MARY
- The company holds all the shares of
- The company holds all the shares of PHARMACIE MARENGO
- The operation takes effect in the accounts on 01-01-2022
- Power of attorney granted to (managing director)
- Discharge granted to MULTIPHARMA
- The deed holds 17 more points.
Merger proposal: MULTIPHARMA takes over CL Pharma, Apoteek Van Schel, Pharmacie Mary, Apotheek Van Wemmel and Pharmacie Marengo4 points ▸
- Merger by absorption
- The operation takes effect in the accounts on 01-01-2022
- Real estate, Apotheek Van Wemmel
- Operation treated as a merger by absorption
- The deed holds 11 more points.
2 directors appointed, 2 resignations and resign · and appointed · General meeting of 10-06-20215 points ▸
- General meeting of 10-06-2021
- resigns as director
- resigns as director
- appointed as director
- appointed as director
Merger: MULTIPHARMA takes over PHARMA-LESSINESThe company holds all the shares of PHARMA-LESSINES · General meeting of 10-06-20216 points ▸
- General meeting of 10-06-2021
- Merger by absorption
- The company holds all the shares of PHARMA-LESSINES
- The operation takes effect in the accounts on 01-01-2021
- Power of attorney granted to (lasthebber)
- Power of attorney granted to (managing director)
- The deed holds 3 more points.
appointed as member of the executive committeeBoard meeting of 06-05-20212 points ▸
- Board meeting of 06-05-2021
- appointed as member of the executive committee
Merger proposal: MULTIPHARMA takes over PHARMA-LESSINES1 point ▸
- The operation takes effect in the accounts on 01-01-2021
- The deed holds 6 more points.
- General meeting of 03-12-2020
- Merger by absorption
- The company holds all the shares of FRAMAGEST
- The company holds all the shares of
- The operation takes effect in the accounts on 01-09-2020
- Power of attorney granted to (managing director)
- The deed holds 5 more points.
8 directors appointed, 2 resignations changes role from managing director to chair of the board · and resign · (day-to-day manager), , (member of the executive committee), (member of the executive committee), (member of the executive committee), (member of the executive committee) and 2 others appointed · Board meeting of 03-12-202022 points ▸
- Board meeting of 03-12-2020
- resigns as director
- appointed as director
- resigns as director
- appointed as director
- resigns as managing director
- appointed as day-to-day manager
- appointed as chair of the board
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-09-2020
- The deed holds 5 more points.
appointed as member of the executive committeeBoard meeting of 23-01-20202 points ▸
- Board meeting of 23-01-2020
- appointed as member of the executive committee
- The deed holds 1 more point.
Capital conversion · Purpose change · Amendment of the articles · Resignations & appointments“1º van apotheken waar farmaceutische zorg wordt verleend, geneesmiddelen en eveneens toilet-en hygiëne-…” (deed in Dutch) · General meeting of 11-06-20203 points ▸
- General meeting of 11-06-2020
- The registered office is at Marie Curie Square 30, 1070 Anderlecht
- Power of attorney granted to (managing director)
- The deed holds 6 more points.
7 directors appointed, , , , , and 1 other7 points ▸
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- appointed as member of the executive committee
- The deed holds 1 more point.
Merger: MULTIPHARMA takes over APOTHEEK VAN DEN BRANDEN and MVT INVESTThe company holds all the shares of APOTHEEK VAN DEN BRANDEN · The company holds all the shares of MVT INVEST · General meeting of 05-12-20198 points ▸
- General meeting of 05-12-2019
- Merger by absorption
- The company holds all the shares of APOTHEEK VAN DEN BRANDEN
- The company holds all the shares of MVT INVEST
- The operation takes effect in the accounts on 01-09-2019
- Real estate, APOTHEEK VAN DEN BRANDEN
- Real estate, MVT INVEST
- Power of attorney granted to
- The deed holds 2 more points.
Powers of attorney granted to , and 5 othersBoard meeting of 07-11-20198 points ▸
- Board meeting of 07-11-2019
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 1 more point.
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-09-2019
- The deed holds 6 more points.
appointed as managing directorBoard meeting of 13-06-20192 points ▸
- Board meeting of 13-06-2019
- appointed as managing director
Merger: MULTIPHARMA takes over PHARMACIE NOUVELLE, BECOFAR, PHARMACIE LIGNE XADE, COGELAB, APOTHEEK GYSSELS and HOET EN C°The company holds all the shares of PHARMACIE NOUVELLE · The company holds all the shares of BECOFAR · The company holds all the shares of PHARMACIE LIGNE XADE · General meeting of 13-06-201911 points ▸
- General meeting of 13-06-2019
- Merger by absorption
- The operation takes effect in the accounts on 01-01-2019
- The company holds all the shares of PHARMACIE NOUVELLE
- The company holds all the shares of BECOFAR
- The company holds all the shares of PHARMACIE LIGNE XADE
- The company holds all the shares of COGELAB
- The company holds all the shares of APOTHEEK GYSSELS
- The company holds all the shares of HOET EN C°
- Power of attorney granted to (lasthebber)
- Real estate, 31-12-2018
- The deed holds 1 more point.
6 directors appointed, 1 statutory auditor appointed, 1 resignation, 1 reappointment resigns as managing director · , , , , , and 1 other appointed · acts as permanent representative · General meeting of 13-06-201912 points ▸
- General meeting of 13-06-2019
- resigns as managing director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as statutory auditor
- acts as permanent representative
- Board meeting of 13-06-2019
- reappointed as chair
- The deed holds 1 more point.
Transfer: DE VOORZORG transfers a branch of activity to MULTIPHARMAGeneral meeting of 16-05-20192 points ▸
- General meeting of 16-05-2019
- Transfer of a branch of activity or universality, 24-04-2018
- The deed holds 2 more points.
Merger proposal: MULTIPHARMA takes over PHARMACIE NOUVELLE, BECOFAR, Pharmacie LIGNE XADE, COGELAB, APOTHEEK GYSSELS and HOET EN C°Board meeting of 21-03-20193 points ▸
- Board meeting of 21-03-2019
- Merger by absorption
- The operation takes effect in the accounts on 01-01-2019
- The deed holds 6 more points.
Merger: MULTIPHARMA takes over MOENS MEDICAL, PHARMACIE ROSEN RENAUDIN, OMNIPHARMA, FLEURUS PHARMA, PHARMA ZEMST and PHARMACIE DU CARREFOURThe company holds all the shares of MOENS MEDICAL · The company holds all the shares of PHARMACIE ROSEN RENAUDIN · The company holds all the shares of OMNIPHARMA · General meeting of 06-12-201811 points ▸
- General meeting of 06-12-2018
- Merger by absorption
- The company holds all the shares of MOENS MEDICAL
- The company holds all the shares of PHARMACIE ROSEN RENAUDIN
- The company holds all the shares of OMNIPHARMA
- The company holds all the shares of FLEURUS PHARMA
- The company holds all the shares of PHARMA ZEMST
- The company holds all the shares of PHARMACIE DU CARREFOUR
- The operation takes effect in the accounts on 01-09-2018
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 8 more points.
Merger proposal: MULTIPHARMA takes over MOENS MEDICAL, PHARMACIE ROSEN RENAUDIN, OMNIPHARMA, FLEURUS PHARMA, PHARMA ZEMST and PHARMACIE DU CARREFOUR2 points ▸
- Merger by absorption
- The operation takes effect in the accounts on 01-09-2018
- The deed holds 6 more points.
Capital decrease of €51,858,000 to €74,130,000The capital fell from €125,988,000 to €74,130,000, cancelling 51,858 shares · General meeting of 14-06-20183 points ▸
- General meeting of 14-06-2018
- The capital was reduced by €51,858,000
- Article 5 of the articles of association amended
- The deed holds 2 more points.
resigns as director appointed as director · General meeting of 14-06-20184 points ▸
- General meeting of 14-06-2018
- Board meeting of 14-06-2018
- resigns as director
- appointed as director
Transfer: DE VOORZORG transfers a branch of activity to MULTIPHARMACapital increase to €127,081,100 · The capital rose from €121,957,100 to €127,081,100, with 5,124 new shares · General meeting of 24-04-20186 points ▸
- General meeting of 24-04-2018
- Board meeting of 05-02-2018
- The capital was increased by €5,124,200
- The operation takes effect in the accounts on 01-01-2018
- Article 5 of the articles of association amended
- Power of attorney granted to
- The deed holds 12 more points.
Transfer proposal: DE VOORZORG transfers a branch of activity to MULTIPHARMABoard meeting of 01-02-20184 points ▸
- Board meeting of 01-02-2018
- Transfer of a branch of activity
- The operation takes effect in the accounts on 01-01-2018
- Power of attorney granted to
- The deed holds 7 more points.
New alternate director appointed, resigned · General meeting of 08-06-20175 points ▸
- General meeting of 08-06-2017
- Board meeting of 08-06-2017
- resigns as director
- appointed as alternate director
- appointed as director
Merger: MULTIPHARMA takes over MAURLYSON, PHARMACIE DELPLACE-STRUYVEN and PHARMACIE FROGNEUXThe company holds all the shares of MAURLYSON · The company holds all the shares of PHARMACIE DELPLACE-STRUYVEN · The company holds all the shares of PHARMACIE FROGNEUX · General meeting of 08-06-201710 points ▸
- General meeting of 08-06-2017
- Merger by absorption
- The company holds all the shares of MAURLYSON
- The company holds all the shares of PHARMACIE DELPLACE-STRUYVEN
- The company holds all the shares of PHARMACIE FROGNEUX
- The operation takes effect in the accounts on 01-01-2017
- Real estate, PHARMACIE DELPLACE-STRUYVEN
- Real estate, PHARMACIE FROGNEUX
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 6 more points.
Merger proposal: MULTIPHARMA takes over MAURLYSON, PHARMACIE DELPLACE-STRUYVEN, PHARMACIE FROGNEUX and FRAMAGEST1 point ▸
- The operation takes effect in the accounts on 01-01-2017
- The deed holds 7 more points.
Merger: MULTIPHARMA takes over VAN DEN BORRE, PHARMACIE MEYLEMANS, PHARMACIE DECLERCQ MC and PHARMANJEThe company holds all the shares of VAN DEN BORRE · The company holds all the shares of PHARMACIE MEYLEMANS · The company holds all the shares of PHARMACIE DECLERCQ MC · General meeting of 21-12-20169 points ▸
- General meeting of 21-12-2016
- Merger by absorption
- The company holds all the shares of VAN DEN BORRE
- The company holds all the shares of PHARMACIE MEYLEMANS
- The company holds all the shares of PHARMACIE DECLERCQ MC
- The company holds all the shares of PHARMANJE
- The operation takes effect in the accounts on 01-09-2016
- Power of attorney granted to
- Power of attorney granted to
- The deed holds 5 more points.
Merger proposal: MULTIPHARMA takes over VAN DEN BORRE, PHARMACIE MEYLEMANS, PHARMACIE DECLERCQ MC and PHARMANJE2 points ▸
- Operation treated as a merger by absorption
- The operation takes effect in the accounts on 01-09-2016
- The deed holds 7 more points.
(chair of the board) and (managing director) reappointedBoard meeting of 09-06-20164 points ▸
- Board meeting of 09-06-2016
- reappointed as chair of the board
- reappointed as chair
- reappointed as managing director
- The deed holds 2 more points.
6 directors appointed, 1 statutory auditor appointed, 1 resignation, 1 reappointment, , , , , and 1 other appointed · resigns as statutory auditor · reappointed as statutory auditor · General meeting of 09-06-201611 points ▸
- General meeting of 09-06-2016
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- resigns as statutory auditor
- reappointed as statutory auditor
- acts as permanent representative
- appointed as statutory auditor
- The deed holds 1 more point.
Transfer: MULTIPAR transfers a branch of activity to MULTIPHARMACapital increase of €112,764,000 to €113,864,000 · 112,764 new shares · The capital rose from €1,100,000 to €113,864,000, with 112,764 new shares · General meeting of 19-05-20166 points ▸
- General meeting of 19-05-2016
- The capital was increased by €112,764,000
- The operation takes effect in the accounts on 01-01-2016
- Transfer of a branch of activity
- Article 5 of the articles of association amended
- Power of attorney granted to
- The deed holds 4 more points.
Transfer proposal: MULTIPAR transfers a branch of activity to MULTIPHARMABoard meeting of 23-03-20163 points ▸
- Board meeting of 23-03-2016
- Transfer of a branch of activity
- The operation takes effect in the accounts on 01-01-2016
- The deed holds 7 more points.
(chair of the board) and (managing director) appointedBoard meeting of 10-11-20153 points ▸
- Board meeting of 10-11-2015
- appointed as chair of the board
- appointed as managing director
Company renamed from PHARMACIE GRANDJEAN to MultipharmaRegistered office moved within Anderlecht · Capital increase of €1,000,000 to €1,100,000 · The capital rose from €100,000 to €1,100,000, with 1,000 new shares · General meeting of 10-11-201515 points ▸
- General meeting of 10-11-2015
- Name change, Multipharma
- The registered office moved to Square Marie Curie 30, 1070 Anderlecht
- The capital is divided into 100 shares
- Legal-form conversion, from private limited company (pre-2019) to coöperatieve vennootschap met beperkte aansprakelijkheid
- resigns as manager
- Discharge granted to (manager)
- The capital was increased by €1,000,000
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- appointed as director
- Net-asset statement, 30-09-2015
- The deed holds 9 more points.
Registered office moved from Châtelet to AnderlechtThe registered office moved from Grand'Rue, 76-6200 Châtelet to Route de Lennik 900, 1070 Anderlecht · resigns as manager · (manager) and (statutory auditor) appointed · General meeting of 01-09-20146 points ▸
- General meeting of 01-09-2014
- resigns as manager
- Discharge granted to (manager)
- appointed as manager
- The registered office moved to Route de Lennik 900, 1070 Anderlecht
- appointed as statutory auditor
changes role from statutory manager to managerGeneral meeting of 20-08-20145 points ▸
- General meeting of 20-08-2014
- The capital is €100,000, divided into 1,000 shares
- resigns as statutory manager
- Article 6 of the articles of association amended
- appointed as manager, not named in the articles
- The deed holds 3 more points.
Registered office moved to ChâteletThe registered office moved from Rue du Wainage, 68. 60 6 to Grand Rue 76, 6200 Châtelet · Board meeting of 05-12-20092 points ▸
- Board meeting of 05-12-2009
- The registered office moved to Grand Rue 76, 6200 Châtelet
- The deed holds 1 more point.
Financial milestones sit on the financial year-end date, not the filing date.
A deed published in both Dutch and French appears here once.
All 37 environmental permit applications
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Multipharma was incorporated on 19 August 2004.1 The registered office moved to Châtelet in 2009 and to Anderlecht in 2014.23 In 2015 the company took the name Multipharma.4 Between 2015 and 2018 the capital was increased 3 times, most recently to €127.1m. After a decrease in 2018 the capital stands at €74.1m.456 42 companies were merged into the company between 2016 and 2025, including STENAPHAR and Farmannso.789 The board currently has 6 members.10
- 1KBO register
- 2Belgian Official Gazette, 23-12-2009
- 3Belgian Official Gazette, 15-09-2014
- 4Belgian Official Gazette, 27-11-2015
- 5Belgian Official Gazette, 14-06-2016
- 6Belgian Official Gazette, 09-05-2018
- 7Belgian Official Gazette, 06-01-2017
- 8Belgian Official Gazette, 24-06-2025
- 9Belgian Official Gazette, 21-10-2025
- 10Belgian Official Gazette, 03-07-2025
Mentions of companies taken over
Show the 10 newest deeds
Show the 10 newest deeds
Show the 10 newest deeds
Show the 10 newest deeds
- 27-01-2021 · Multipharma
- 27-01-2021 · Multipharma
- 27-01-2021 · SOCIETE PHARMACEUTIQUE BRUXELLOISE
- 15-10-2020 · SOCIETE PHARMACEUTIQUE BRUXELLOISE
- 15-10-2020 ·
- 15-10-2020 · Multipharma
- 15-10-2020 · Multipharma
- 23-09-2020 · SOCIETE PHARMACEUTIQUE BRUXELLOISE
- 08-01-2020 · SOCIETE PHARMACEUTIQUE BRUXELLOISE
- 04-07-2019 · SOCIETE PHARMACEUTIQUE BRUXELLOISE